Our mission is to advocate for legal access, responsible use, and ethical regulation of psychedelic medicine in Missouri and at the federal level. We collaborate with regulatory agencies, private sector associations, and key stakeholders to establish robust frameworks that ensure patient access and harm reduction. By promoting clinical research, we support FDA Compassionate Access pathways, regulatory approvals, and rescheduling efforts. We champion the legal production and availability of botanical psychedelics while upholding the rights of Native American and other Indigenous communities to access these medicines in accordance with their sacred traditions.
Membership Includes:
1. Advocacy & Influence – Members can actively help shape policies and regulations, ensuring that psilocybin therapy is accessible and responsibly implemented.
Tier I
- Receive reports on key legislation, policy trends, and regulatory developments that may impact members.
- Assist with Identifying influential policymakers and strategic allies who can help advance the association’s mission.
- We will serve as a legislative liaison, representing members before lawmakers and government agencies on priority issues.
- We will Host webinars and Q&A sessions to educate members about psilocybin policy and legislative developments.
- Members are encouraged to contribute scientific research, clinical success stories, and personal experiences to educate licensed therapists, the public, and policymakers on the therapeutic benefits of psilocybin.
Tier II (Includes all Tier I services)
- We will monitor proposed legislation, rules, regulations, policies and procedures, which may have an impact on our members.
- Schedule and facilitate meetings with lawmakers to advocate for psilocybin policy changes.
- Send notified of committee hearings on bills related to psilocybin.
- Track and report on Floor Action when psilocybin legislation is debated in the Senate and House of Representatives.
- Receive assistance in drafting position papers that reflect the association’s policy goals.
- Actively participate in online forums and professional discussion groups to exchange insights and advocacy strategies.
- Receive invitations to speak at social gatherings and industry events to share expertise and promote awareness.
Tier III: (Includes all Tier I & Tier II services)
- Assist with drafting legislative language that reflects the association’s goals.
- Provide bill sponsors with fact sheets and key materials prepared by the association to support legislation during hearings and floor debates.
- Schedule and attend personal meetings between our members and legislators or government officials to advocate for policy changes.
- Assist in drafting testimony for hearings on psilocybin legislation to ensure clear and compelling advocacy.
- Provide summaries of committee hearings on select psilocybin-related bills to keep members informed.
- Organize large-scale awareness campaigns, rallies, and petitions to build public and legislative support.
- Help members understand and implement new policies, ensuring a smooth transition into their work.
2. Access to Research & Education
- Provide members with the latest scientific studies, expert insights, and training opportunities related to psilocybin-assisted therapy.
- Receive exclusive access to industry newsletters featuring policy updates, research findings, and advocacy efforts.
- Attend private and semi-private roundtable discussions with experts, policymakers, and industry leaders.
- Participate in specialized training webinars designed to enhance knowledge and advocacy skills.
- Gain access to comprehensive research studies showcasing the efficacy of psilocybin therapy.
- Stay informed about clinical trials, breakthrough findings, and success stories from psilocybin-assisted therapy.
3. Public Awareness & Stigma Reduction
- By supporting the movement, members contribute to reducing misconceptions about psilocybin and promoting its potential benefits for mental health.
- Members are encouraged to contribute scientific research, clinical success stories, and personal experiences to educate licensed therapists, the public, and policymakers on the therapeutic benefits of psilocybin.
- Engage in open and respectful discussions to help shift public perception of psilocybin therapy from stigma to understanding.
- Actively participate in online forums and professional discussion groups to exchange insights and advocacy strategies.
- Receive invitations to speak at social gatherings and industry events to share expertise and promote awareness.
4. Networking & Community – Members can connect with like-minded individuals, including healthcare professionals, researchers, and policymakers, fostering collaboration and support.
- Build connections with therapists, patients, and advocacy organizations to strengthen coalitions and amplify a unified voice in support of psilocybin therapy.
- Receive exclusive invitations to private and semi-private roundtable discussions with industry leaders and policymakers.
- Gain access to the Psychedelic Missouri Conferences, providing opportunities for networking, education, and advocacy.
5. Exclusive Events & Conferences – Our organization host events, workshops, and conferences where members can engage with experts and stay informed on the latest developments. We provide information about other conferences in Missouri and other states.
2025 Psychedelic Missouri Conferences
- Springfield - Aug. 2025
- Columbia - Aug. 2025
- St. Louis - Oct. 2025
- Kansas City - Nov. 2025
Psychedelic Missouri is an organization dedicated to advocating for legal access to psychedelics in the state. The organization focuses on public outreach, legislative efforts, and hosting conferences to promote awareness and support for psychedelic-assisted therapies.